Exploring how specific proteins affect pain sensitivity in fruit flies.
Investigation of Armadillo/ß-catenin Mechanisms Influencing Nociceptive Sensitivity in Drosophila
['FUNDING_R15'] · UNIVERSITY OF NEW ENGLAND · NIH-10653377
This study is looking at how a protein in fruit flies affects their response to pain, and by understanding this, researchers hope to find new ways to help people who experience unusual pain.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF NEW ENGLAND (nih funded) |
| Locations | 1 site (BIDDEFORD, UNITED STATES) |
| Trial ID | NIH-10653377 on ClinicalTrials.gov |
What this research studies
This research investigates the mechanisms by which a protein called Armadillo, related to ß-catenin, influences how fruit flies respond to painful stimuli. By using genetic techniques, the researchers will manipulate the expression of this protein in specific nerve cells of the flies to observe changes in their pain sensitivity. The findings aim to uncover new targets for pain medications that could lead to better treatments for abnormal pain in humans.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals suffering from chronic pain conditions who are seeking alternative pain management options.
Not a fit: Patients with acute pain conditions or those who do not respond to genetic-based therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective pain management therapies with fewer side effects than current opioid treatments.
How similar studies have performed: Other research has shown success in using genetic models like Drosophila to identify pain mechanisms, suggesting this approach has potential for meaningful discoveries.
Where this research is happening
BIDDEFORD, UNITED STATES
- UNIVERSITY OF NEW ENGLAND — BIDDEFORD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GANTER, GEOFFREY — UNIVERSITY OF NEW ENGLAND
- Study coordinator: GANTER, GEOFFREY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.